An observational study in Common Bile Duct Calculi, sponsored by Assiut University. Not yet recruiting. Per ClinicalTrials.gov, last updated 2023-04-21.
Sponsored by Assiut University · Observational
The goal of this work is to assess the best time to perform LC combined with LCBD exploration and the feasibility and safety of such procedure in patients with combined GBS and CBDS after failure of ERCP extraction of CBD stones .
199 studies on the registry are indexed under Gallstones; 35 are open to participants now.
This study's planned enrollment of 50 is below the median of 200 across 70 observational studies indexed under Gallstones.
Browse Gallstones studies →Assiut University is the lead sponsor of 5,078 studies on the registry; 2,178 are open to participants now.
Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
All patients that presented with calcular obstructive jaundice 2ry to CBD stones and failed of extraction of common bile duct stone by ERCP.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Early laparoscopic exploration of common bile duct after failure of extraction of common bile duct stones by ERCP
Device: laparoscopy
late laparoscopic exploration of common bile duct after failure of extraction of common bile duct stones by ERCP
Device: laparoscopy
laparoscopic exploration of common bile duct
intraoperative complications
1. Assess the operative time in hours 2. intraoperative blood loss in millilitres 3. intraoperative organ injury (yes or no) 4. conversion to open surgery (yes or no)
Time frame: Baseline
postoperative complications
1. Postoperative bleeding in millilitres 2. biliary leakage in millilitres 3. missed stone (yes or no) 4. recumbency complications which are monitored for 30 days postoperatively. 5.Overall length of hospital stay and if Intensive Care Unit (ICU) stay needed will also be recorded in days.
Time frame: Baseline
No study locations are listed for this record.
Start is estimated for Sep 2023; primary completion for Sep 2025, 24 months later.
Of 23 observational studies under Gallstones, half reached primary completion within 34 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 61. This study's planned 24 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.